ID   END-1
AC   CVCL_B5JE
DR   Wikidata; Q111733198
RX   PubMed=380083;
RX   PubMed=1176207;
RX   PubMed=6171715;
CC   Characteristics: Established from an undifferentiated endometrial carcinoma serially transplanted into nude mice (PubMed=1176207).
CC   Doubling time: 14 hours (PubMed=1176207).
DI   NCIt; C40156; Endometrial undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
RX   PubMed=380083;
RA   Carrel S., Gross N., Heumann D., Mach J.-P.;
RT   "Expression of 'Ia-like' antigens on cells from a human endometrial
RT   carcinoma cell line, END-1.";
RL   Transplantation 27:431-433(1979).
//
RX   PubMed=1176207; DOI=10.1002/ijc.2910160406;
RA   Merenda C., Sordat B., Mach J.-P., Carrel S.;
RT   "Human endometrial carcinomas serially transplanted in nude mice and
RT   established in continuous cell lines.";
RL   Int. J. Cancer 16:559-570(1975).
//
RX   PubMed=6171715; DOI=10.1016/0161-5890(81)90102-4;
RA   Carrel S., Tosi R., Gross N., Tanigaki N., Carmagnola A.L.,
RA   Accolla R.S.;
RT   "Subsets of human Ia-like molecules defined by monoclonal
RT   antibodies.";
RL   Mol. Immunol. 18:403-411(1981).
//